Fig. 4

The therapeutic effect of FeDOX@cellMBs on orthotopic GBM mice. (A) Schematic diagram of treatment schedule. (B) GBM growth monitored by bioluminescence imaging (n = 3). (C) Semiquantitative statistic results of luminescence intensity. (D) Expression of Ki67 and TUNEL staining of orthotopic GBM tissue. (E) Semiquantitative statistic results of Ki67 expression. (F) Semi-quantitative statistic results of TUNEL staining. (n = 3, x ± SD. * P < 0.05, ** P < 0.01, ns: no significant)